Safety and Efficacy of Flecainide in Subjects with Long QT‐3 Syndrome (ΔKPQ Mutation): A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

Background: We conducted a study of chronic therapy with flecainide versus placebo in a small group of LQT‐3 patients with the ΔKPQ deletion to evaluate the safety and efficacy of flecainide in this genetic disorder. In vitro studies have shown that flecainide provides correction of the impaired ina...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Noninvasive Electrocardiol
Main Authors: Moss, Arthur J., Windle, John R., Hall, W. Jackson, Zareba, Wojciech, Robinson, Jennifer L, McNitt, Scott, Severski, Patricia, Rosero, Spencer, Daubert, James P., Qi, Ming, Cieciorka, Michael, Manalan, Allan S.
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing, Inc. 2005
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6932190/
https://ncbi.nlm.nih.gov/pubmed/16274417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1542-474X.2005.00077.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki